Bernie Sanders gaining influence over upcoming FDA funding legislation

Senator Bernie Sanders of Vermont is set to hold major influence over upcoming negotiations for a crucial Food and Drug Administration funding bill, STAT News reported. The shift follows a Democratic landslide victory in the midterm elections. Sanders will likely lead the Senate health committee, placing him in a position to shape the upcoming legislation. [1]

The Food and Drug Administration relies on user fees collected from pharmaceutical companies to fund its reviews of new medicines, according to STAT News. The current Prescription Drug User Fee Act is set to expire on Sept. 30. If Congress fails to renew the law before that date, it could disrupt the agency's ability to approve new treatments. [1]

Sanders has served as a senior United States senator from Vermont since 2007 and is a long-standing critic of the pharmaceutical industry. He has previously chaired the Senate Health, Education, Labor, and Pensions Committee and introduced legislation such as the Medicare for All Act. [3][5]

STAT News reported that Sanders could use his leading role in drafting the new funding bill to push for reforms within the program. Observers expect senior Democrats to play a central role in guiding the user fee negotiations to ensure continuity in agency operations. [1]